Japan IP court backs Toray's anti-itching drug patent extension over Sawai challenge
Japan’s Intellectual Property High Court upheld Toray Industries' patent extension for its anti-itch drug Remitch, rejecting Sawai Pharmaceutical’s claim that the extension exceeded legal limits. The court found that the approved...To view the full article, register now.
Already a subscriber? Click here to view full article